Cachexia measured by bioelectrical impedance vector analysis and risk of infection in women with rheumatoid arthritis

Midori Ogata-Medel, Luis Llorente, Andrea Hinojosa-Azaola, Mariel Lozada-Mellado, Juan Antonio Pineda-Juarez, Hector Isaac Rocha-Gonzalez, Lilia Castillo-Martinez, Midori Ogata-Medel, Luis Llorente, Andrea Hinojosa-Azaola, Mariel Lozada-Mellado, Juan Antonio Pineda-Juarez, Hector Isaac Rocha-Gonzalez, Lilia Castillo-Martinez

Abstract

Rheumatoid arthritis (RA) patients have a higher frequency of infections than the healthy population. The reason has yet to be explained but involves several factors, of which body composition and rheumatoid cachexia are often overlooked. This study aimed to evaluate whether patients with cachexia, measured by bioelectrical impedance vector analysis, are at an increased risk of developing infections compared with patients without cachexia. A secondary analysis of 186 women with RA enrolled in a randomized trial (ClinicalTrials.gov ID: NCT02900898, September 14, 2016) was completed. Medical records and phone calls were used to record infectious events diagnosed and treated during follow-up. Hazard ratios were calculated using Cox proportional hazard regression analysis, and a predictive model of infection was created. After 36 months of follow-up, 62 patients (26.7% non-cachectic and 44.3% cachectic, p < 0.01) developed at least one infectious event. The most common site of was the urinary tract, followed by the lungs and respiratory tract. The presence of cachexia (HR 1.90, 95% CI 1.15-3.13) and the use of glucocorticoids (HR 1.77, 95% CI 1.01-3.09) were associated with infection in univariate and multivariate models. Body mass index (BMI), smoking, and methotrexate use were not associated with a higher frequency of infections. The presence of cachexia and the use of glucocorticoids were identified as predictors of infections in a cohort of female RA patients. More extensive measurements of body composition should be performed beyond BMI in RA patients to better understand its impact and to prevent additional comorbidities and complications. Key Points • The presence of cachexia measured by bioelectrical impedance vector analysis was associated with infectious events in women with rheumatoid arthritis, whereas body mass index did not show an association. • Glucocorticoids were the only drug associated with a higher frequency of infection. None of the disease-modifying antirheumatic drugs, including methotrexate, showed an association.

Keywords: Bioelectrical impedance vector analysis; Body composition; Infection; Rheumatoid cachexia.

© 2022. The Author(s), under exclusive licence to International League of Associations for Rheumatology (ILAR).

Figures

Fig. 1
Fig. 1
Kaplan–Meier survival curves at 36 months for any infectious event stratified by BIVA-cachexia status

References

    1. Smitten AL, Choi HK, Hochberg MC, Suissa S, Simon TA, et al. The risk of hospitalized infection in patients with rheumatoid arthritis. J Rheumatol. 2008;35(3):387–393.
    1. Doran MF, Crowson CS, Pond GR, O’Fallon WM, Gabriel SE. Frequency of infection in patients with rheumatoid arthritis compared with controls. Arthritis Rheum. 2002;46(9):2287–2293. doi: 10.1002/art.10524.
    1. Gonzalez A, Kremers HM, Crowson CS, Nicola PJ, Davis JM, et al. The widening gap between rheumatoid arthritis patients and the general population. Arthritis Rheum. 2007;56(11):3583–3587. doi: 10.1002/art.22979.
    1. Atzeni F, Masala IF, di Franco M, Sarzi-Puttini P. Infections in rheumatoid arthritis. Curr Opin Rheumatol. 2017;4:323–330. doi: 10.1097/BOR.0000000000000389.
    1. Muscaritolli M, Anker SD, Argilés J, Aversa Z, Bauer JM, Muscaritolli M, Anker SD, Argilés J, Aversa Z, Bauer JM, et al. Consensus definition of sarcopenia, cachexia and pre-cachexia: joint document elaborated by Special Interest Groups (SIG) "cachexia-anorexia in chronic wasting diseases" and "nutrition in geriatrics". Clin Nutr. 2012;29(2):154–159. doi: 10.1016/j.clnu.2009.12.004.
    1. Walsmith J, Roubenoff R. Cachexia in rheumatoid arthritis. Int J Cardiol. 2002;85(1):89–99. doi: 10.1016/S0167-5273(02)00237-1.
    1. Masuko K. Rheumatoid cachexia revisited: a metabolic co-morbidity in rheumatoid arthritis. Front Nutr. 2014;24(1):20.
    1. Santo RCE, Fernandes KZ, Lora Priscila S, Filippin LI, Xavier RM (2018) Prevalence of rheumatoid cachexia in rheumatoid arthritis: a systematic review and meta-analysis. J Cachexia Sarcopenia Muscle 9:816–825
    1. Summers GD, Deighton CM, Rennie MJ, Booth AH. Rheumatoid cachexia: a clinical perspective. Rheumatology. 2008;47:1124–1131. doi: 10.1093/rheumatology/ken146.
    1. Pineda-Juárez JA, Lozada-Mellado M, Ogata-Medel M, Hinojosa-Azaola A, Santillán-Díaz C, et al. Body composition evaluated by body mass index and bioelectrical impedance vector analysis in women with rheumatoid arthritis. Nutrition. 2018;53:49–53. doi: 10.1016/j.nut.2018.01.004.
    1. Camina-Martín MA, de Mateo-Silleras B, Barrera-Ortega S, Domínguez-Rodríguez L, Redondo del Río MP. Specific bioelectrical impedance vector analysis is more accurate than classic BIVA to detect changes in body composition and in nutritional status in institutionalized elderly with dementia. Experimental Gerontol. 2014;57:264–271. doi: 10.1016/j.exger.2014.06.016.
    1. Santillán-Díaz C, Ramírez-Sánchez N, Espinosa-Morales R, Orea-Tejeda A, Llorente L, et al. Prevalence of rheumatoid cachexia assessed by bioelectrical impedance vector analysis and its relation with physical function. Clin Rheumatol. 2018;37(3):607–614. doi: 10.1007/s10067-017-3889-x.
    1. Piccoli A, Nescolarde LD, Rosell J. Análisis convencional y vectorial de bioimpedancia en la práctica clínica. Nefrologia. 2002;27(3):228–238.
    1. García-Morales M, Lozada-Mellado M, Hinojosa-Azaola A, Llorente L, Ogata-Medel M, et al. Effect of a dynamic exercise program in combination with a Mediterranean diet on quality of life in women with rheumatoid arthritis. J Clin Rheumatol. 2020;27(7S Suppl 2):S116–S122. doi: 10.1097/RHU.0000000000001064.
    1. Lohman TG, Roche AF, Martorell R. Anthropometric standardization reference manual. Chicago: Human Kinetics Books; 1988.
    1. Espinosa-Cuevas MA, Rivas-Rodríguez L, González-Medina EC, Atilano-Carsi X, Miranda-Alatriste P, et al. Vectores de impedancia bioleléctrica para la composición corporal en población mexicana. Rev Invest Clín. 2007;59(1):15–24.
    1. Doran MF, Crowson CS, Pond GR, O’Fallon WM, Gabriel SE. Predictors of infection in rheumatoid arthritis. Arthritis Rheum. 2002;46(9):2294–2300. doi: 10.1002/art.10529.
    1. Lacaille D, Guh DP, Abrahamowicz M, Anis AH, Esdaile JM. Use of nonbiologic disease-modifying antirheumatic drugs and risk of infection in patients with rheumatoid arthritis. Arthritis Rheum. 2008;59(8):1074–1081. doi: 10.1002/art.23913.
    1. Youssef J, Novosad SA, Winthrop KL. Infection risk and safety of corticosteroid use. Rheum Dis Clin North Am. 2016;42(1):157–176. doi: 10.1016/j.rdc.2015.08.004.
    1. Smolen JS, Landewé R, Breedveld FC, Dougados M, Emery P. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs. Ann Rheum Dis. 2010;69(6):964–975. doi: 10.1136/ard.2009.126532.
    1. George MD, Baker JF, Winthrop K, Hsu JY, Qufei Wu, et al. Risk for serious infection with low-dose glucocorticoids in patients with rheumatoid arthritis. Ann Intern Med 1. 2020;173(11):870–878. doi: 10.7326/M20-1594.
    1. Lightfoot A, McArdle A, Griffiths RD. Muscle in defense. Crit Care Med. 2009;37(20):384–390. doi: 10.1097/CCM.0b013e3181b6f8a5.
    1. Toshima T, Shirabe K, Kurihara T, Itoh S, Harimoto N, et al. Profile of plasma amino acids values as a predictor of sepsis in patients following living donor liver transplantation: special reference to sarcopenia and postoperative early nutrition. Hepatol Res. 2015;45:1170–1177. doi: 10.1111/hepr.12484.
    1. Dobner J, Kaser S. Body mass index and the risk of infection - from underweight to obesity. Clin Microbiol Infect. 2018;24(1):24–28. doi: 10.1016/j.cmi.2017.02.013.
    1. Isoda K, Tsuji S, Harada Y, Yoshimura M, Nakabayashi A, Sato M, Nagano H, Kim DS, Hashimoto J, Ohshima S. Potential of the prognostic nutritional index to determine the risk factor for severe infection in elderly patients with rheumatoid arthritis. Mod Rheumatol. 2022 doi: 10.1093/mr/roac001.
    1. Torres-Ruiz J, Pérez-Fragoso A, Maravillas-Montero JL, Llorente L, Mejía-Domínguez NR et al (2021) Redefining COVID-19 severity and prognosis: the role of clinical and immunobiotypes. Front Immunol 12
    1. Peris-Moreno D, Taillandier D, Polge C. MuRF1/TRIM63, master regulator of muscle mass. Int J Mol Sci. 2020;21(18):6663. doi: 10.3390/ijms21186663.

Source: PubMed

Patrocinadores y Colaboradores

Condiciones médicas

Intervenciones de drogas

3
Suscribir